3-iodobenzylguanidine has been researched along with Opsoclonus-Myoclonus Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bares, R; Ebinger, M; Handgretinger, R; Schäfer, JF; Storz, C; Tsiflikas, I | 1 |
Herman, TE; Siegel, MJ | 1 |
Applegate, K; Lee, ND; McGarvey, CK; Sokol, DK | 1 |
3 other study(ies) available for 3-iodobenzylguanidine and Opsoclonus-Myoclonus Syndrome
Article | Year |
---|---|
Diagnostic value of whole-body MRI in Opsoclonus-myoclonus syndrome: a clinical case series (3 case reports).
Topics: 3-Iodobenzylguanidine; Adrenalectomy; Female; Ganglioneuroblastoma; Humans; Infant; Magnetic Resonance Imaging; Male; Opsoclonus-Myoclonus Syndrome; Radionuclide Imaging; Sensitivity and Specificity; Whole Body Imaging | 2019 |
Ataxia without opsoclonus: right lumbar sympathetic trunk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Ataxia; Child, Preschool; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Neuroblastoma; Opsoclonus-Myoclonus Syndrome; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Ultrasonography | 2009 |
False-positive metaiodobenzylguanidine scan for neuroblastoma in a child with opsoclonus-myoclonus syndrome treated with adrenocorticotropic hormone (acth).
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Child, Preschool; False Positive Reactions; Female; Hormones; Humans; Neuroblastoma; Opsoclonus-Myoclonus Syndrome; Radionuclide Imaging; Radiopharmaceuticals | 2006 |